Minireview: MicroRNA function in pancreatic β cells

Molecular Endocrinology

Volumn 28, Issue 12, 2014, Pages 1922-1933

  Özcan, Sabire ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; DICER; DICER1 PROTEIN; MICRORNA; MICRORNA 124A; MICRORNA 145; MICRORNA 15; MICRORNA 184; MICRORNA 200; MICRORNA 21; MICRORNA 24; MICRORNA 29; MICRORNA 30; MICRORNA 33A; MICRORNA 375; MICRORNA 7; MICRORNA 9; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL MATURATION; HUMAN; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; METABOLISM;

HUMANS; INSULIN-SECRETING CELLS; MICRORNAS;

EID: 84914164079     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1306     Document Type: Review

References (98)

1. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294(5543):858-862.
2. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001; 294(5543):853-858.
3. Orom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell. 2008;30(4):460-471.
4. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA. 2008;105(5):1608-1613.
5. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007; 318(5858):1931-1934.
6. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-233.
7. Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci USA. 2005; 102(31):10898-10903.
8. Chong MM, Rasmussen JP, Rudensky AY, Littman DR. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med. 2008;205(9):2005-2017.
9. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet. 2007;39(3):380-385.
10. O’Carroll D, Mecklenbrauker I, Das PP, et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 2007;21(16):1999-2004.
11. Bernstein E, Kim SY, Carmell MA, et al. Dicer is essential for mouse development. Nat Genet. 2003;35(3):215-217.
12. Wienholds E, Koudijs MJ, van Eeden FJ, Cuppen E, Plasterk RH. The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat Genet. 2003;35(3):217-218.
13. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58-63.
14. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433(7027):769-773.
15. Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006;126(6):1203-1217.
16. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432(7014): 226-230.
17. Dumortier O, Van Obberghen E. MicroRNAs in pancreas development. Diabetes Obes Metab. 2012;14(suppl 3):22-28.
18. Guay C, Jacovetti C, Nesca V, Motterle A, Tugay K, Regazzi R. Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction. Diabetes Obes Metab. 2012;14(suppl 3):12-21.
19. Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes. 2007;56(12):2938-2945.
20. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage:NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development. 2002;129(10):2447-2457.
21. Morita S, Hara A, Kojima I, et al. Dicer is required for maintaining adult pancreas. PLoS One. 2009;4(1):e4212.
22. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429(6987):41-46.
23. Melkman-Zehavi T, Oren R, Kredo-Russo S, et al. miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J. 2011;30(5):835-845.
24. Kalis M, Bolmeson C, Esguerra JL, et al. β-Cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One. 2011;6(12):e29166.
25. Mandelbaum AD, Melkman-Zehavi T, Oren R, et al. Dysregulation of Dicer1 in β cells impairs islet architecture and glucose metabolism. Exp Diabetes Res. 2012;2012:470302.
26. Kanji MS, Martin MG, Bhushan A. Dicer1 is required to repress neuronal fate during endocrine cell maturation. Diabetes. 2013; 62(5):1602-1611.
27. Dueck A, Meister G. Assembly and function of small RNA-argonaute protein complexes. Biol Chem. 2014;395(6):611-629.
28. Meister G. Argonaute proteins: functional insights and emerging roles. Nat Rev Genet. 2013;14(7):447-459.
29. Tattikota SG, Rathjen T, McAnulty SJ, et al. Argonaute2 mediates compensatory expansion of the pancreatic β cell. Cell Metab. 2014; 19(1):122-134.
30. Tattikota SG, Sury MD, Rathjen T, et al. Argonaute2 regulates the pancreatic β-Cell secretome. Mol Cell Proteomics. 2013;12(5): 1214-1225.
31. Correa-Medina M, Bravo-Egana V, Rosero S, et al. MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr Patterns. 2009;9(4): 193-199.
32. Joglekar MV, Patil D, Joglekar VM, et al. The miR-30 family of microRNAs confer epithelial phenotype to human pancreatic cells. Islets. 2009;1(2):137-147.
33. Bravo-Egana V, Rosero S, Molano RD, et al. Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun. 2008;366(4):922-926.
34. Kredo-Russo S, Mandelbaum AD, Lennox KA, Behlke MA, et al. Pancreas-enriched miRNA refines endocrine cell differentiation. Development. 2012;139(16):3021-3031.
35. Yasuda T, Kajimoto Y, Fujitani Y, et al. PAX6 mutation as a genetic factor common to aniridia and glucose intolerance. Diabetes. 2002; 51(1):224-230.
36. Wang Y, Liu J, Liu C, Naji A, Stoffers DA. MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells. Diabetes. 2013;62(3):887-895.
37. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12(1):21-35.
38. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest. 2001;108(11):1631-1638.
39. Hamada S, Hara K, Hamada T, et al. Upregulation of the mammalian target of rapamycin complex 1 pathway by Ras homolog enriched in brain in pancreatic β-cells leads to increased β-Cell mass and prevention of hyperglycemia. Diabetes. 2009;58(6):1321-1332.
40. Latreille M, Hausser J, Stutzer I, et al. MicroRNA-7a regulates pancreatic β cell function. J Clin Invest. 2014;124(6):2722-2735.
41. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem. 2006;281(37):26932-26942.
42. Fukuda M. Rab27 and its effectors in secretory granule exocytosis: a novel docking machinery composed of a Rab27.effector complex. Biochem Soc Trans. 2006;34(Pt 5):691-695.
43. Gomi H, Mizutani S, Kasai K, Itohara S, Izumi T. Granuphilin molecularly docks insulin granules to the fusion machinery. J Cell Biol. 2005;171(1):99-109.
44. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic β-cells. Diabetes. 2008;57(10):2708-2717.
45. Ramachandran D, Roy U, Garg S, Ghosh S, Pathak S, Kolthur-Seetharam U. Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic β-islets. FEBS J. 2011;278(7):1167-1174.
46. Saunders LR, Sharma AD, Tawney J, et al. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY). 2010;2(7):415-431.
47. Moynihan KA, Grimm AA, Plueger MM, et al. Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2005;2(2):105-117.
48. Joglekar MV, Parekh VS, Mehta S, Bhonde RR, Hardikar AA. MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin 3. Dev Biol. 2007;311(2):603-612.
49. Lee CS, De Leon DD, Kaestner KH, Stoffers DA. Regeneration of pancreatic islets after partial pancreatectomy in mice does not involve the reactivation of neurogenin-3. Diabetes. 2006;55(2):269-272.
50. Gradwohl G, Dierich A, LeMeur M, Guillemot F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA. 2000;97(4):1607-1611.
51. Roggli E, Britan A, Gattesco S, et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β-cells. Diabetes. 2010;59(4):978-986.
52. Bravo-Egana V, Rosero S, Klein D, et al. Inflammation-mediated regulation of MicroRNA expression in transplanted pancreatic islets. J Transplant. 2012;2012:723614.
53. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and β-Cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5(4): 219-226.
54. Regazzi R, Sadoul K, Meda P, Kelly RB, Halban PA, Wollheim CB. Mutational analysis of VAMP domains implicated in Ca2+-induced insulin exocytosis. EMBO J. 1996;15(24):6951-6959.
55. Wheeler MB, Sheu L, Ghai M, et al. Characterization of SNARE protein expression in β cell lines and pancreatic islets. Endocrinology. 1996;137(4):1340-1348.
56. Yaekura K, Julyan R, Wicksteed BL, et al. Insulin secretory deficiency and glucose intolerance in Rab3A null mice. J Biol Chem. 2003;278(11):9715-9721.
57. Ruan Q, Wang T, Kameswaran V, et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic β cell death. Proc Natl Acad Sci USA. 2011;108(29):12030-12035.
58. Vinciguerra M, Sgroi A, Veyrat-Durebex C, Rubbia-Brandt L, Buhler LH, Foti M. Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology. 2009;49(4): 1176-1184.
59. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2008;283(2):1026-1033.
60. Peyton M, Stellrecht CM, Naya FJ, Huang HP, Samora PJ, Tsai MJ. β3, a novel helix-loop-helix protein, can act as a negative regulator of β2 and MyoD-responsive genes. Mol Cell Biol. 1996;16(2):626-633.
61. Iguchi H, Ikeda Y, Okamura M, et al. SOX6 attenuates glucosestimulated insulin secretion by repressing PDX1 transcriptional activity and is down-regulated in hyperinsulinemic obese mice. J Biol Chem. 2005;280(45):37669-37680.
62. Zhu Y, You W, Wang H, et al. MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-Cell dysfunction. Diabetes. 2013;62(9):3194-3206.
63. Vijayaraghavan J, Maggi EC, Crabtree JS. miR-24 regulates menin in the endocrine pancreas. Am J Physiol Endocrinol Metab. 2014; 307(1):E84-E92.
64. Karnik SK, Hughes CM, Gu X, et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA. 2005;102(41):14659-14664.
65. Crabtree JS, Scacheri PC, Ward JM, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA. 2001;98(3):1118-1123.
66. Crabtree JS, Scacheri PC, Ward JM, et al. Of mice and MEN1: Insulinomas in a conditional mouse knockout. Mol Cell Biol. 2003; 23(17):6075-6085.
67. Karnik SK, Chen H, McLean GW, et al. Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science. 2007;318(5851):806-809.
68. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR-29a and miR-29b contribute to pancreatic β-Cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol. 2011;31(15): 3182-3194.
69. Bagge A, Clausen TR, Larsen S, et al. MicroRNA-29a is up-regulated in β-cells by glucose and decreases glucose-stimulated insulin secretion. Biochem Biophys Res Commun. 2012;426(2):266-272.
70. Ishihara H, Wang H, Drewes LR, Wollheim CB. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in β cells. J Clin Invest. 1999;104(11):1621-1629.
71. Zhao C, Wilson MC, Schuit F, Halestrap AP, Rutter GA. Expression and distribution of lactate/monocarboxylate transporter isoforms in pancreatic islets and the exocrine pancreas. Diabetes. 2001;50(2):361-366.
72. Roggli E, Gattesco S, Caille D, et al. Changes in microRNA expression contribute to pancreaticβ-Cell dysfunction in prediabeticNOD mice. Diabetes. 2012;61(7):1742-1751.
73. Baran-Gale J, Fannin EE, Kurtz CL, Sethupathy P. β Cell 5′-shifted isomiRs are candidate regulatory hubs in type 2 diabetes. PLoS One. 2013;8(9):e73240.
74. He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol. 2007; 21(11):2785-2794.
75. Herrera BM, Lockstone HE, Taylor JM, et al. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of type 2 diabetes. BMC Med Genomics. 2009;2:54.
76. Pandey AK, Verma G, Vig S, Srivastava S, Srivastava AK, Datta M. miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol Cell Endocrinol. 2011;332(1-2):125-133.
77. Kurtz CL, Peck BC, Fannin EE, et al. MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes. Diabetes. 2014;63(9):3141-3148.
78. Kong L, Zhu J, Han W, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011;48(1):61-69.
79. Ozcan S. MiR-30 family and EMT in human fetal pancreatic islets. Islets. 2009;1(3):283-285.
80. Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucoseregulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription. RNA. 2009;15(2):287-293.
81. Zhao X, Mohan R, Ozcan S, Tang X. MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. J Biol Chem. 2012;287(37):31155-31164.
82. Liao X, Xue H, Wang YC, et al. Matched miRNA and mRNA signatures from an hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions. J Cell Sci. 2013; 126(Pt 17):3848-3861.
83. Kim JW, You YH, Jung S, et al. miRNA-30a-5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity-induced β cell dysfunction in rodent models. Diabetologia. 2013;56(4):847-855.
84. Wijesekara N, Zhang LH, Kang MH, Abraham T, Bhattacharjee A, Warnock GL, Verchere CB, Hayden MR. miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes. 2012;61(3):653-658.
85. Kang MH, Zhang LH, Wijesekara N, et al. Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145. Arterioscler Thromb Vasc Biol. 2013;33(12):2724-2732.
86. Brunham LR, Kruit JK, Pape TD, et al. β-Cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med. 2007;13(3):340-347.
87. Baroukh N, Ravier MA, Loder MK, et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic β-Cell lines. J Biol Chem. 2007;282(27):19575-19588.
88. Joglekar MV, Parekh VS, Hardikar AA. New pancreas from old: microregulators of pancreas regeneration. Trends Endocrinol Metab. 2007;18(10):393-400.
89. Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem. 2008;389(3):305-312.
90. Jing G, Westwell-Roper C, Chen J, Xu G, Verchere CB, Shalev A. Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through miR-124a and FoxA2. J Biol Chem. 2014; 289(17):11807-11815.
91. Klein D, Misawa R, Bravo-Egana V, et al. MicroRNA expression in α and β cells of human pancreatic islets. PLoS One. 2013;8(1): e55064.
92. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10(5):593-601.
93. Poy MN, Spranger M, Stoffel M. microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab. 2007;9(suppl 2):67-73.
94. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol. 2007;5(8):e203.
95. Poy MN, Hausser J, Trajkovski M, et al. miR-375 maintains normal pancreatic α- and β-Cell mass. Proc Natl Acad Sci USA. 2009; 106(14):5813-5818.
96. Wei R, Yang J, Liu GQ, et al. Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells. Gene. 2013;518(2):246-255.
97. Erener S, Mojibian M, Fox JK, Denroche HC, Kieffer TJ. Circulating miR-375 as a biomarker of β-Cell death and diabetes in mice. Endocrinology. 2013;154(2):603-608.
98. van Rooij E, Kauppinen S. Development of microRNA therapeutics is coming of age. EMBO Mol Med. 2014;6(7):851-864.